We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
EYE vs. AHCO: Which Stock Should Value Investors Buy Now?
Read MoreHide Full Article
Investors with an interest in Medical - Products stocks have likely encountered both National Vision (EYE - Free Report) and DFB Healthcare Acquisitions Corp. (AHCO - Free Report) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits.
Currently, National Vision has a Zacks Rank of #2 (Buy), while DFB Healthcare Acquisitions Corp. has a Zacks Rank of #3 (Hold). This means that EYE's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analyst outlook. However, value investors will care about much more than just this.
Value investors also tend to look at a number of traditional, tried-and-true figures to help them find stocks that they believe are undervalued at their current share price levels.
Our Value category highlights undervalued companies by looking at a variety of key metrics, including the popular P/E ratio, as well as the P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that have been used by value investors for years.
EYE currently has a forward P/E ratio of 46.31, while AHCO has a forward P/E of 100.80. We also note that EYE has a PEG ratio of 2.60. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. AHCO currently has a PEG ratio of 4.03.
Another notable valuation metric for EYE is its P/B ratio of 3.34. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. For comparison, AHCO has a P/B of 63.
Based on these metrics and many more, EYE holds a Value grade of B, while AHCO has a Value grade of C.
EYE has seen stronger estimate revision activity and sports more attractive valuation metrics than AHCO, so it seems like value investors will conclude that EYE is the superior option right now.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
EYE vs. AHCO: Which Stock Should Value Investors Buy Now?
Investors with an interest in Medical - Products stocks have likely encountered both National Vision (EYE - Free Report) and DFB Healthcare Acquisitions Corp. (AHCO - Free Report) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits.
Currently, National Vision has a Zacks Rank of #2 (Buy), while DFB Healthcare Acquisitions Corp. has a Zacks Rank of #3 (Hold). This means that EYE's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analyst outlook. However, value investors will care about much more than just this.
Value investors also tend to look at a number of traditional, tried-and-true figures to help them find stocks that they believe are undervalued at their current share price levels.
Our Value category highlights undervalued companies by looking at a variety of key metrics, including the popular P/E ratio, as well as the P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that have been used by value investors for years.
EYE currently has a forward P/E ratio of 46.31, while AHCO has a forward P/E of 100.80. We also note that EYE has a PEG ratio of 2.60. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. AHCO currently has a PEG ratio of 4.03.
Another notable valuation metric for EYE is its P/B ratio of 3.34. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. For comparison, AHCO has a P/B of 63.
Based on these metrics and many more, EYE holds a Value grade of B, while AHCO has a Value grade of C.
EYE has seen stronger estimate revision activity and sports more attractive valuation metrics than AHCO, so it seems like value investors will conclude that EYE is the superior option right now.